ATE352629T1 - Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden - Google Patents
Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bildenInfo
- Publication number
- ATE352629T1 ATE352629T1 AT96945935T AT96945935T ATE352629T1 AT E352629 T1 ATE352629 T1 AT E352629T1 AT 96945935 T AT96945935 T AT 96945935T AT 96945935 T AT96945935 T AT 96945935T AT E352629 T1 ATE352629 T1 AT E352629T1
- Authority
- AT
- Austria
- Prior art keywords
- kvlqt1
- long
- syndrome
- gene
- acid sequence
- Prior art date
Links
- 108010011185 KCNQ1 Potassium Channel Proteins 0.000 title abstract 6
- 208000004731 long QT syndrome Diseases 0.000 title abstract 6
- 102100037444 Potassium voltage-gated channel subfamily KQT member 1 Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241000772415 Neovison vison Species 0.000 title abstract 2
- 102000004257 Potassium Channel Human genes 0.000 title abstract 2
- 108020001213 potassium channel Proteins 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 108091006146 Channels Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000002547 new drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1901495P | 1995-12-22 | 1995-12-22 | |
| US73938396A | 1996-10-29 | 1996-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE352629T1 true ATE352629T1 (de) | 2007-02-15 |
Family
ID=26691739
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96945935T ATE352629T1 (de) | 1995-12-22 | 1996-12-20 | Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden |
| AT96946233T ATE427993T1 (de) | 1995-12-22 | 1996-12-20 | EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96946233T ATE427993T1 (de) | 1995-12-22 | 1996-12-20 | EIN GEN DES ßLANGEN QT SYNDROMSß (LONG QT SYNDROM), WELCHES KVLQT1 KODIERT UND SEINE WECHSELWIRKUNG MIT MINK |
Country Status (11)
| Country | Link |
|---|---|
| EP (3) | EP2085478A1 (de) |
| JP (2) | JP3449419B2 (de) |
| AT (2) | ATE352629T1 (de) |
| AU (2) | AU714527B2 (de) |
| CA (1) | CA2240737C (de) |
| DE (2) | DE69637895D1 (de) |
| DK (1) | DK0876491T3 (de) |
| ES (1) | ES2325820T3 (de) |
| NZ (2) | NZ330744A (de) |
| PT (1) | PT876491E (de) |
| WO (2) | WO1997023632A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277978B1 (en) * | 1995-12-22 | 2001-08-21 | University Of Utah Research Foundation | KVLQT1—a long QT syndrome gene |
| US6274332B1 (en) * | 1995-12-22 | 2001-08-14 | Univ. Of Utah Research Foundation | Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| US6413719B1 (en) | 1997-10-24 | 2002-07-02 | University Of Utah Research Foundation | KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies |
| GB9726339D0 (en) * | 1997-12-13 | 1998-02-11 | Zeneca Ltd | Human-derived tissue-specific potassium channel |
| WO1999043696A1 (en) * | 1998-02-25 | 1999-09-02 | Icagen Inc. | Human potassium channel genes |
| US6071720A (en) | 1998-04-29 | 2000-06-06 | Incyte Pharmaceuticals, Inc. | Delayed rectifier potassium channel subunit |
| US6794161B1 (en) | 1999-01-26 | 2004-09-21 | Neurosearch A/S | Potassium channels and genes encoding these potassium channels |
| EP1147134B1 (de) * | 1999-01-26 | 2006-10-11 | Neurosearch A/S | Kaliumkanäle und für diese kaliumkanäle kodierende gene |
| JP2003529331A (ja) | 1999-08-09 | 2003-10-07 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション | Ｑｔ延長症候群遺伝子ｋｖｌｑｔ１およびｓｃｎ５ａの改変ならびにその検出方法 |
| WO2001027323A1 (en) * | 1999-10-08 | 2001-04-19 | Vanderbilt University | Method of screening for susceptibility to drug-induced cardiac arrhythmia |
| EP1176197A1 (de) * | 2000-06-16 | 2002-01-30 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Transgenes Tiermodel für Herzarrythmien |
| EP2363152A1 (de) * | 2000-09-06 | 2011-09-07 | Johns Hopkins University | Methoden zur Behandlung von Herzarrhythmie |
| US8013133B2 (en) * | 2003-04-25 | 2011-09-06 | Medtronic, Inc. | Genetic modification of targeted regions of the cardiac conduction system |
| US10917454B1 (en) | 2019-08-01 | 2021-02-09 | Rohde & Schwarz Gmbh & Co. Kg | System and method for ATC voice quality assurance |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| CA1188246A (en) | 1981-08-31 | 1985-06-04 | Jerry L. Gregory | Immobilized microbe recycle apparatus |
| US4868105A (en) | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| IL103059A0 (en) | 1991-09-30 | 1993-02-21 | Boehringer Ingelheim Int | Conjugates for introducing nucleic acid into higher eucaryotic cells |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US5599673A (en) * | 1995-03-09 | 1997-02-04 | University Of Utah Research Foundation | Long QT syndrome genes |
-
1996
- 1996-12-20 NZ NZ330744A patent/NZ330744A/xx not_active IP Right Cessation
- 1996-12-20 JP JP52372697A patent/JP3449419B2/ja not_active Expired - Lifetime
- 1996-12-20 NZ NZ330743A patent/NZ330743A/xx not_active IP Right Cessation
- 1996-12-20 AT AT96945935T patent/ATE352629T1/de not_active IP Right Cessation
- 1996-12-20 WO PCT/US1996/019917 patent/WO1997023632A1/en not_active Application Discontinuation
- 1996-12-20 AU AU17428/97A patent/AU714527B2/en not_active Expired
- 1996-12-20 EP EP09156996A patent/EP2085478A1/de not_active Withdrawn
- 1996-12-20 JP JP52370497A patent/JP2001519646A/ja not_active Ceased
- 1996-12-20 DE DE69637895T patent/DE69637895D1/de not_active Expired - Lifetime
- 1996-12-20 AT AT96946233T patent/ATE427993T1/de active
- 1996-12-20 DK DK96946233T patent/DK0876491T3/da active
- 1996-12-20 EP EP96945935A patent/EP0870041B1/de not_active Expired - Lifetime
- 1996-12-20 ES ES96946233T patent/ES2325820T3/es not_active Expired - Lifetime
- 1996-12-20 PT PT96946233T patent/PT876491E/pt unknown
- 1996-12-20 DE DE69636870T patent/DE69636870T2/de not_active Expired - Lifetime
- 1996-12-20 WO PCT/US1996/019756 patent/WO1997023598A2/en active IP Right Grant
- 1996-12-20 CA CA002240737A patent/CA2240737C/en not_active Expired - Lifetime
- 1996-12-20 EP EP96946233A patent/EP0876491B1/de not_active Expired - Lifetime
- 1996-12-20 AU AU19512/97A patent/AU714041B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0870041B1 (de) | 2007-01-24 |
| WO1997023632A1 (en) | 1997-07-03 |
| CA2240737C (en) | 2009-09-29 |
| JP3449419B2 (ja) | 2003-09-22 |
| EP0876491A1 (de) | 1998-11-11 |
| PT876491E (pt) | 2009-07-14 |
| NZ330743A (en) | 1999-07-29 |
| EP0870041A4 (de) | 2002-01-23 |
| EP2085478A1 (de) | 2009-08-05 |
| DE69636870D1 (de) | 2007-03-15 |
| DK0876491T3 (da) | 2009-07-06 |
| EP0876491A4 (de) | 2001-12-19 |
| JP2001519646A (ja) | 2001-10-23 |
| JP2001501445A (ja) | 2001-02-06 |
| EP0876491B1 (de) | 2009-04-08 |
| ES2325820T3 (es) | 2009-09-18 |
| AU714527B2 (en) | 2000-01-06 |
| DE69637895D1 (de) | 2009-05-20 |
| WO1997023598A2 (en) | 1997-07-03 |
| NZ330744A (en) | 1999-02-25 |
| DE69636870T2 (de) | 2007-11-08 |
| AU1742897A (en) | 1997-07-17 |
| AU1951297A (en) | 1997-07-17 |
| EP0870041A2 (de) | 1998-10-14 |
| AU714041B2 (en) | 1999-12-16 |
| CA2240737A1 (en) | 1997-07-03 |
| ATE427993T1 (de) | 2009-04-15 |
| WO1997023598A3 (en) | 1997-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE352629T1 (de) | Kvlqt1 - ein gen des long-qt-syndroms, welches für kvlqt1 kodiert und welches sich mit mink zusammensetzt, um iks-kaliumkanäle des herzens zu bilden | |
| ATE182180T1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
| PT991421E (pt) | Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa | |
| IL153052A0 (en) | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
| WO1994023638A3 (en) | Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome | |
| EP3262215A1 (de) | Mikrobiom-diagnostika | |
| NO904001D0 (no) | Fremgangsmaate og anordning for amperometrisk diagnoseanalyse. | |
| FR2703693B1 (fr) | Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic. | |
| PT815261E (pt) | Diagnostico de adn com base em espectometria de massa | |
| ATE131533T1 (de) | Diagnostika und impfstoffe für mycobacteria in der volksgesundheit, in der medizinischen und veterinären praxis | |
| Matsumoto et al. | Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis | |
| DE68928728D1 (de) | Diagnose von retinoblastoma | |
| EE05497B1 (et) | Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha | |
| Pande et al. | Electroconvulsive therapy in delusional and non-delusional depressive disorder | |
| MX2022002880A (es) | Ensayo basado en sangre para diagnosticar y tratar fosforilacion de tau especifica con base en el sitio. | |
| Ling et al. | Blood microbiota as a potential noninvasive diagnostic biomarker for liver fibrosis in severely obese patients: choose carefully | |
| HUP0303491A2 (hu) | Magas vérnyomás kvantitatív diagnosztikai elemzése | |
| Hickman-Brenner et al. | Priority of Providencia rustigianii Hickman-Brenner, Farmer, Steigerwalt, and Brenner 1983 over Providencia friedericiana Müller 1983 | |
| Bixler | A STUDY OF THE INTERPERSONAL NEEDS OF BULIMIC WOMEN. | |
| Neuman | Developing a clinical profile for multiple personality disorder for diagnostic and therapeutic purposes. | |
| Kelley | Correction: Henry Clay and the Great State of Kentucky |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |